A review of WHO International Standards for botulinum antitoxins
| Autor: | Dorothea Sesardic, R.G.A. Jones, Michael J. Corbel |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Serotype
medicine.medical_specialty Botulinum Antitoxin Bioengineering Biology World Health Organization medicine.disease_cause Applied Microbiology and Biotechnology Microbiology Wound Botulism Mice Inhalational botulism medicine Animals Humans Intensive care medicine Pharmacology Food poisoning General Immunology and Microbiology Infant Botulism General Medicine Reference Standards medicine.disease Freeze Drying Calibration Clostridium botulinum Antitoxin Biotechnology |
| Zdroj: | Biologicals. 34:223-226 |
| ISSN: | 1045-1056 |
| DOI: | 10.1016/j.biologicals.2005.11.009 |
| Popis: | Clostridium botulinum produces the most potent known toxins, with seven distinct serotypes currently defined (A-G). These toxins can cause a life threatening systemic toxicity whether through natural causes such as food poisoning, infant botulism, wound botulism, or through use as bio-terror agents (e.g. inhalational botulism). It was realised early on that standard reference botulinum antitoxins were required to reduce the variation between assays and ensure a consistent potency of therapeutic antitoxins and vaccines, and to define the serotype. This led to the International Unit being defined by the World Health Organisation (WHO) in the 1960s with the establishment of the first International Standards (IS) for serotypes A-F. Since then botulinum antitoxin ISs have been used world wide as the 'yard stick' to measure the neutralising potency of antitoxins. These primary WHO ISs are used to calibrate in house working reagents that are more extensively utilised. A definition of the International Unit for serotype G antitoxin has yet to be defined or accepted by the WHO and urgently needs addressing. However, before September 11th 2001 there was very little interest in botulinum antitoxin IS and as a result stocks of most of the original preparations are now completely exhausted or depleted and replacements long overdue. We have reviewed the extensive history and availability of the primary WHO ISs and interim materials. All type A and B antitoxin materials were recently assayed and their relative activities confirmed against the original IS preparations. The recent increase in demand for these materials has further exacerbated the shortage. We describe here the production and characterization of stable freeze dried potential candidate replacements along with a new prospective first IS for type G antitoxin. Available toxin A reference preparations are also briefly reviewed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect